{"category": "ham", "to_address": "undisclosed-recipients: ;", "from_address": "Buddhima Lokuge <Buddhima.Lokuge@newyork.msf.org>", "subject": "[Ip-health] MSF briefing note- Thailand, Abbott and the Second Line AIDS Crisis", "body": "This briefing note prepared by Doctors Without Borders - Medecins Sans\nFrontieres (MSF) examines recent developments in Thailand in the context\nof the second line HIV-AIDS crisis. It highlights MSFs experience treating\npatients with HIV/AIDS in Thailand. This experience demonstrates the\nimportance of TRIPS flexibilities in ensuring access to essential\nmedicines. Given the unprecedented retaliation by Abbott Laboratories\nagainst Thailand's lawful actions as well as other patent disputes\noccurring internationally as a result of the use of TRIPS flexibilities by\ndeveloping countries we ask... what good are the flexibilities built into\ninternational trade agreements if countries will be penalized for using\nthem?\n\nFor briefing note see\nhttp://www.doctorswithoutborders.org/news/access/thailand_briefingdoc_04-11-2007.cfm\n\nFor a history of MSF's efforts to obtain heat stable Kaletra for our\npatients from Abbott Laboratories see:\nhttp://www.doctorswithoutborders.org/news/hiv-aids/kaletra_briefingdoc.cfm\n\nBuddhima Lokuge\nCampaign for Access to Essential Medicines\nDoctors Without Borders-Medecins Sans Frontieres (MSF)\nNew York\n---------------------------\n_______________________________________________\nIp-health mailing list\nIp-health@lists.essential.org\nhttp://lists.essential.org/mailman/listinfo/ip-health\n\n"}